Apimeds Pharmaceuticals US Inc
AMEX:APUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Apimeds Pharmaceuticals US Inc
AMEX:APUS
|
US |
|
Bekasi Asri Pemula Tbk PT
IDX:BAPA
|
ID |
|
S4 Capital PLC
F:9S4
|
UK |
|
Tecma Solutions SpA
MIL:TCM
|
IT |
|
E
|
Elia Group SA
DUS:E4S
|
BE |
|
P
|
PT Temas Tbk
IDX:TMAS
|
ID |
|
I
|
Insulet Corp
XMUN:GOV
|
US |
|
Universal Music Group NV
AEX:UMG
|
NL |
|
Vallourec SA
OTC:VLOUF
|
FR |
|
Tasfoods Ltd
ASX:TFL
|
AU |
|
E
|
Econpile Holdings Bhd
KLSE:ECONBHD
|
MY |
|
A
|
Aldel Financial II Inc
NASDAQ:ALDF
|
US |
|
F
|
First Tellurium Corp
CNSX:FTEL
|
CA |
|
Flanigan's Enterprises Inc
F:0DY
|
US |
|
Ibersol SGPS SA
F:L34
|
PT |
|
Allo Bank Indonesia Tbk PT
IDX:BBHI
|
ID |
|
T
|
TSA Group Bhd
KLSE:TSA
|
MY |
|
T
|
Telefonaktiebolaget LM Ericsson
XHAM:ERCB
|
SE |
|
Global Cord Blood Corp
OTC:CORBF
|
HK |
|
Nextleaf Solutions Ltd
OTC:OILFF
|
CA |
|
P
|
Paychex Inc
F:PCX
|
US |
|
E
|
Envases del Pacifico SA
SGO:EDELPA
|
CL |
|
C
|
Canter Resources Corp
OTC:CNRCF
|
CA |
|
K
|
Kencoa Aerospace Corp
KOSDAQ:274090
|
KR |
Bankruptcy Probability
Apimeds Pharmaceuticals US Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Apimeds Pharmaceuticals US Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
A
|
Apimeds Pharmaceuticals US Inc
AMEX:APUS
|
4.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
503.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
190.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
98.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Apimeds Pharmaceuticals US Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Apimeds Pharmaceuticals US Inc has total debt of 13.9m USD. This includes both short-term (13.9m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.